Yang YM - Search Results

1

Identification of a novel class of dithiolethiones that prevent hepatic insulin resistance via the adenosine monophosphate-activated protein kinase-p70 ribosomal S6 kinase-1 pathway.

Bae EJ, Yang YM, Kim JW, Kim SG. Bae EJ, et al. Among authors: yang ym. Hepatology. 2007 Sep;46(3):730-9. doi: 10.1002/hep.21769. Hepatology. 2007. PMID: 17668885

2

Abrogation of hyperosmotic impairment of insulin signaling by a novel class of 1,2-dithiole-3-thiones through the inhibition of S6K1 activation.

Bae EJ, Yang YM, Kim SG. Bae EJ, et al. Among authors: yang ym. Mol Pharmacol. 2008 May;73(5):1502-12. doi: 10.1124/mol.107.044347. Epub 2008 Feb 5. Mol Pharmacol. 2008. PMID: 18252807

3

Metadoxine, an ion-pair of pyridoxine and L-2-pyrrolidone-5-carboxylate, blocks adipocyte differentiation in association with inhibition of the PKA-CREB pathway.

Yang YM, Kim HE, Ki SH, Kim SG. Yang YM, et al. Arch Biochem Biophys. 2009 Aug 15;488(2):91-9. doi: 10.1016/j.abb.2009.07.007. Epub 2009 Jul 14. Arch Biochem Biophys. 2009. PMID: 19607801

4

Inhibition of SREBP-1c-mediated hepatic steatosis and oxidative stress by sauchinone, an AMPK-activating lignan in Saururus chinensis.

Kim YW, Kim YM, Yang YM, Kim TH, Hwang SJ, Lee JR, Kim SC, Kim SG. Kim YW, et al. Among authors: yang ym. Free Radic Biol Med. 2010 Feb 15;48(4):567-78. doi: 10.1016/j.freeradbiomed.2009.12.006. Epub 2009 Dec 11. Free Radic Biol Med. 2010. PMID: 20005944

5

G(alpha)12/13 inhibition enhances the anticancer effect of bortezomib through PSMB5 downregulation.

Yang YM, Lee S, Nam CW, Ha JH, Jayaraman M, Dhanasekaran DN, Lee CH, Kwak MK, Kim SG. Yang YM, et al. Carcinogenesis. 2010 Jul;31(7):1230-7. doi: 10.1093/carcin/bgq097. Epub 2010 May 17. Carcinogenesis. 2010. PMID: 20478922

6

Inhibition of LXRα-dependent steatosis and oxidative injury by liquiritigenin, a licorice flavonoid, as mediated with Nrf2 activation.

Kim YW, Kim YM, Yang YM, Kay HY, Kim WD, Lee JW, Hwang SJ, Kim SG. Kim YW, et al. Among authors: yang ym. Antioxid Redox Signal. 2011 Mar 1;14(5):733-45. doi: 10.1089/ars.2010.3260. Epub 2010 Nov 1. Antioxid Redox Signal. 2011. Retraction in: Antioxid Redox Signal. 2012 Feb 1;16(3):292. doi: 10.1089/ars.2011.4389 PMID: 20677908 Retracted.

7

AMPK-associated signaling to bridge the gap between fuel metabolism and hepatocyte viability.

Yang YM, Han CY, Kim YJ, Kim SG. Yang YM, et al. World J Gastroenterol. 2010 Aug 14;16(30):3731-42. doi: 10.3748/wjg.v16.i30.3731. World J Gastroenterol. 2010. PMID: 20698033 Free PMC article. Review.

8

Inhibition of liver X receptor-α-dependent hepatic steatosis by isoliquiritigenin, a licorice antioxidant flavonoid, as mediated by JNK1 inhibition.

Kim YM, Kim TH, Kim YW, Yang YM, Ryu DH, Hwang SJ, Lee JR, Kim SC, Kim SG. Kim YM, et al. Among authors: yang ym. Free Radic Biol Med. 2010 Dec 1;49(11):1722-34. doi: 10.1016/j.freeradbiomed.2010.09.001. Epub 2010 Sep 16. Free Radic Biol Med. 2010. PMID: 20840863

9

Transactivation of genes encoding for phase II enzymes and phase III transporters by phytochemical antioxidants.

Yang YM, Noh K, Han CY, Kim SG. Yang YM, et al. Molecules. 2010 Sep 7;15(9):6332-48. doi: 10.3390/molecules15096332. Molecules. 2010. PMID: 20877225 Free PMC article. Review.

10

Rimonabant, a cannabinoid receptor type 1 inverse agonist, inhibits hepatocyte lipogenesis by activating liver kinase B1 and AMP-activated protein kinase axis downstream of Gα i/o inhibition.

Wu HM, Yang YM, Kim SG. Wu HM, et al. Among authors: yang ym. Mol Pharmacol. 2011 Nov;80(5):859-69. doi: 10.1124/mol.111.072769. Epub 2011 Jul 29. Mol Pharmacol. 2011. PMID: 21803969

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,273 results

Search Page

Filters